Recruiting

NCT Number: NCT01731353

FungiScope - A Global Emerging Fungal Infection Registry

The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Invasive Fungal Disease Bacterial Infections and Mycoses Infections Invasive Fungal Infections Mycoses

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Cologne

Cologne, North Rhine-Westphalia, 50937, Germany

Location status: Recruiting

Location contact

Danila Seidel, PhD

CONTACT

[email protected]

+49 221 478 ext. 97343

Oliver A Cornely, Prof.

CONTACT

[email protected]

+49 221 478 ext. 6494

Philipp Köhler, MD

SUB_INVESTIGATOR

About this study

The specific objectives are:

To determine the fungal species causing invasive fungal infection in different parts of the world.
To determine the clinical pattern of disease and document procedures performed for confirmation of the diagnosis.
To describe the therapeutic regimens used and their efficacy.
To share clinical isolates among the contributors of Fungiscope.
To develop molecular biology tools for identification of strains in histopathologically proven invasive fungal infection.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Cultural, histopathological, antigen or DNA evidence of invasive fungal infection

Exclusion criteria

Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci
Endemic fungal infection such as coccidioidomycosis or histoplasmosis
Colonisation or other non-invasive infection

Treatment and study plan

Primary outcomes

Treatment efficacy of emerging fungal infections

Time frame: At 90 days from diagnosis

failure, stable disease, partial response or complete response

Study contacts

Contact information is provided by the study sponsor or research team.

Oliver A Cornely, Prof.

CONTACT

[email protected]

+49 221 478 ext. 6494

Sponsors and collaborators

Lead sponsor

University of Cologne

Other

Collaborators

Basilea Pharmaceutica
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
F2G Biotech GmbH
Matinas Biopharma, Inc
Pfizer

Registry information

Acronym: FungiScope

Important dates

Study start: 2003
Primary completion: 2026
Study completion: 2026
First posted: Nov 21, 2012
Registry last updated: Dec 5, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting